<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang X</submitter><funding>NIA NIH HHS</funding><pagination>1959</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9689874</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(11)</volume><pubmed_abstract>The epigenome likely interacts with traditional and genetic risk factors to influence blood pressure. We evaluated whether 13 previously reported DNA methylation sites (CpGs) are associated with systolic (SBP) or diastolic (DBP) blood pressure, both individually and aggregated into methylation risk scores (MRS), in 3070 participants (including 437 African ancestry (AA) and 2021 European ancestry (EA), mean age = 70.5 years) from the Health and Retirement Study. Nine CpGs were at least nominally associated with SBP and/or DBP after adjusting for traditional hypertension risk factors (&lt;i>p&lt;/i> &lt; 0.05). MRS&lt;sub>SBP&lt;/sub> was positively associated with SBP in the full sample (β = 1.7 mmHg per 1 standard deviation in MRS&lt;sub>SBP&lt;/sub>; &lt;i>p&lt;/i> = 2.7 × 10&lt;sup>-5&lt;/sup>) and in EA (β = 1.6; &lt;i>p&lt;</pubmed_abstract><journal>Genes</journal><pubmed_title>The Interplay of Epigenetic, Genetic, and Traditional Risk Factors on Blood Pressure: Findings from the Health and Retirement Study.</pubmed_title><pmcid>PMC9689874</pmcid><funding_grant_id>R01AG055406</funding_grant_id><funding_grant_id>R01AG067592</funding_grant_id><funding_grant_id>U01AG009740</funding_grant_id><pubmed_authors>Kardia SLR</pubmed_authors><pubmed_authors>Ammous F</pubmed_authors><pubmed_authors>Faul JD</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Zhao W</pubmed_authors><pubmed_authors>Ware EB</pubmed_authors><pubmed_authors>Smith JA</pubmed_authors><pubmed_authors>Lin L</pubmed_authors><pubmed_authors>Ratliff SM</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Interplay of Epigenetic, Genetic, and Traditional Risk Factors on Blood Pressure: Findings from the Health and Retirement Study.</name><description>The epigenome likely interacts with traditional and genetic risk factors to influence blood pressure. We evaluated whether 13 previously reported DNA methylation sites (CpGs) are associated with systolic (SBP) or diastolic (DBP) blood pressure, both individually and aggregated into methylation risk scores (MRS), in 3070 participants (including 437 African ancestry (AA) and 2021 European ancestry (EA), mean age = 70.5 years) from the Health and Retirement Study. Nine CpGs were at least nominally associated with SBP and/or DBP after adjusting for traditional hypertension risk factors (&lt;i>p&lt;/i> &lt; 0.05). MRS&lt;sub>SBP&lt;/sub> was positively associated with SBP in the full sample (β = 1.7 mmHg per 1 standard deviation in MRS&lt;sub>SBP&lt;/sub>; &lt;i>p&lt;/i> = 2.7 × 10&lt;sup>-5&lt;/sup>) and in EA (β = 1.6; &lt;i>p&lt;</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2025-06-01T02:49:14.146Z</modification><creation>2025-06-01T02:49:14.146Z</creation></dates><accession>S-EPMC9689874</accession><cross_references><pubmed>36360196</pubmed><doi>10.3390/genes13111959</doi></cross_references></HashMap>